A Review of Prostate Cancer Screening Guidelines for African American Veterans

Russell Roberts Arthi Reddy, S. Divya, Packianathan Satyaseelan, G. Shankar, V. Srinivasan
{"title":"A Review of Prostate Cancer Screening Guidelines for African American Veterans","authors":"Russell Roberts Arthi Reddy, S. Divya, Packianathan Satyaseelan, G. Shankar, V. Srinivasan","doi":"10.23937/2378-3419/1410097","DOIUrl":null,"url":null,"abstract":"Objectives: Prostate cancer is the one of the commonest cancers in American men and the second leading cause of cancer deaths. In 2012, the US Preventative Task Force recommended against the prostate specific antigen-based screening test for prostate cancer due to overtreatment of low-risk disease and lack of impact on outcomes. In the general population, African-American men have 60% higher incidence and 200-300% greater mortality rate from prostate cancer than Caucasian men. Additionally, many veterans have been exposed to chemicals that increase incidence of high-risk prostate cancer. Considering these factors, we examine whether or not it is appropriate to screen African-American veteran males for prostate cancer. Methodology: We performed a PubMed and Google Scholar search using pertinent terms, such as African-American veteran, prostate cancer, mortality, PSA density, molecular markers, and Agent Orange. The articles that were relevant to the clinical, molecular, social, and health policy aspects of the diagnosis and treatment of prostate cancer in African-American veterans were analyzed. The data was then summarized. Results: After surveying the literature, there were several areas where the African-American veteran population differed from their Caucasian counterparts: Incidence, clinical course, social differences, PSA levels, mortality rate, and molecular markers. A subset of the veteran population was also exposed to Agent Orange, which has been shown to increase the incidence of aggressive forms of prostate cancer. Lastly, the current USPTF guidelines recommending against prostate cancer screening were based on patient cohorts containing disproportionately low numbers of African-Americans, limiting their extension to the African-American veteran population. Conclusion: After reviewing and summarizing the literature, we contend that a need exists to develop and implement more targeted prostate cancer screening guidelines for African-American veterans.","PeriodicalId":13873,"journal":{"name":"International journal of cancer and clinical research","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cancer and clinical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2378-3419/1410097","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Objectives: Prostate cancer is the one of the commonest cancers in American men and the second leading cause of cancer deaths. In 2012, the US Preventative Task Force recommended against the prostate specific antigen-based screening test for prostate cancer due to overtreatment of low-risk disease and lack of impact on outcomes. In the general population, African-American men have 60% higher incidence and 200-300% greater mortality rate from prostate cancer than Caucasian men. Additionally, many veterans have been exposed to chemicals that increase incidence of high-risk prostate cancer. Considering these factors, we examine whether or not it is appropriate to screen African-American veteran males for prostate cancer. Methodology: We performed a PubMed and Google Scholar search using pertinent terms, such as African-American veteran, prostate cancer, mortality, PSA density, molecular markers, and Agent Orange. The articles that were relevant to the clinical, molecular, social, and health policy aspects of the diagnosis and treatment of prostate cancer in African-American veterans were analyzed. The data was then summarized. Results: After surveying the literature, there were several areas where the African-American veteran population differed from their Caucasian counterparts: Incidence, clinical course, social differences, PSA levels, mortality rate, and molecular markers. A subset of the veteran population was also exposed to Agent Orange, which has been shown to increase the incidence of aggressive forms of prostate cancer. Lastly, the current USPTF guidelines recommending against prostate cancer screening were based on patient cohorts containing disproportionately low numbers of African-Americans, limiting their extension to the African-American veteran population. Conclusion: After reviewing and summarizing the literature, we contend that a need exists to develop and implement more targeted prostate cancer screening guidelines for African-American veterans.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
非裔美国退伍军人前列腺癌筛查指南综述
目的:前列腺癌是美国男性最常见的癌症之一,也是癌症死亡的第二大原因。2012年,美国预防工作小组(US preventive Task Force)建议,由于对低风险疾病的过度治疗和对预后缺乏影响,不要使用基于前列腺特异性抗原的前列腺癌筛查试验。在一般人群中,非裔美国男性的前列腺癌发病率比白种人高60%,死亡率比白种人高200-300%。此外,许多退伍军人接触的化学物质会增加高风险前列腺癌的发病率。考虑到这些因素,我们检查是否适合筛查非裔美国退伍军人男性前列腺癌。方法:我们使用相关术语进行PubMed和Google Scholar搜索,如非裔美国退伍军人、前列腺癌、死亡率、PSA密度、分子标记和橙剂。本文分析了非裔美国退伍军人前列腺癌诊断和治疗的临床、分子、社会和卫生政策方面的相关文章。然后对数据进行总结。结果:在调查了文献之后,非洲裔美国退伍军人与白种人在几个方面存在差异:发病率、临床病程、社会差异、PSA水平、死亡率和分子标记。一部分退伍军人也暴露在橙剂中,橙剂已被证明会增加侵袭性前列腺癌的发病率。最后,目前的USPTF指南建议不进行前列腺癌筛查是基于非裔美国人的患者群体,其数量少得不成比例,限制了非裔美国退伍军人的扩展。结论:在回顾和总结文献后,我们认为有必要为非裔美国退伍军人制定和实施更有针对性的前列腺癌筛查指南。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Epidemiological Study of Penile Cancer in Northeast Brazil Punicic Acid Inhibits Proliferation and Induces Apoptosis in Human MCF-7 Breast Cancer Cells Intensity Modulated Radiation Therapy vs. Volumetric Modulated Arc Therapy in Locally Advanced Unresectable Pancreatic Cancer: Dosimetric Study Alterations of Serum Lipids Profiles in Patients with Head and Neck Cancers Intercalary Endoprosthetic Reconstruction for Long Bone Defects of the Lower Extremity
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1